SCHEMBL7080414

SCHEMBL7080414

Cc1nccn1CCCC(=O)c1ccc(C(F)(F)F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
ALDH1A1 P00352 3/20 0.46
KMT2A Q03164 2/20 0.46
POLB P06746 1/20 0.46
KCNH2 Q12809 1/20 0.46
NOS1 P29475 1/20 0.45
ALPL P05186 2/20 0.44
ALPG P10696 2/20 0.44
ALPI P09923 1/20 0.44
PLAA Q9Y263 1/20 0.44
DRD2 P14416 1/20 0.44
MMP1 P03956 1/20 0.44
GFER P55789 1/20 0.43
PTPN1 P18031 1/20 0.42
GSK3B P49841 1/20 0.42
KDM4E B2RXH2 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CA12 O43570 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6950320 0.86 NPC1 (0.53) ALDH1A1KMT2APOLBKCNH2NOS1
SCHEMBL6948828 0.83 ALDH1A1 (0.51) HDAC1HDAC8ALDH1A1KMT2APOLB
SCHEMBL11144610 0.78 MMP1 (0.46) ALDH1A1KMT2APOLBNOS1ALPL
SCHEMBL6954441 0.76 SLC6A4 (0.61) ALDH1A1KMT2APOLBKCNH2KDM4E
Hydrochloric Acid SCHEMBL6952683 0.75 SLC6A4 (0.60) ALDH1A1KMT2APOLBKCNH2KDM4E
SCHEMBL6943126 0.75 ALDH1A1 (0.50) ALDH1A1KMT2APOLBKCNH2NOS1
SCHEMBL6943246 0.74 TBXAS1 (0.62) HDAC1HDAC8POLBNOS1SMN1; SMN2
SCHEMBL6947633 0.74 ESR1 (0.52) ALDH1A1KMT2APOLBNOS1ALPL
SCHEMBL26488900 0.73 ALDH1A1 (0.61) ALDH1A1KMT2APOLBKDM4EHTT
SCHEMBL6943140 0.73 MAPT (0.56) ALDH1A1KMT2APOLBNOS1ALPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0709378-B1 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds AVENTIS PHARMA INC (US) 2003-03-19 EP disclosed
US-5770740-A TREATING DEPRESSION AND OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1998-06-23 US disclosed
US-5696142-A TREATING DEPRESSION, OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-12-09 US disclosed
US-5686447-A ANTIDEPRESSANTS, OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-11-11 US disclosed
US-5686483-A TREATING DEPRESSION AND OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-11-11 US disclosed
US-5686446-A ANTIDEPRESSANTS, OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-11-11 US disclosed
US-5684021-A Aminoalkyloximes for treating depression and affective disorders HOECHST MARION ROUSSEL, INC. (US) 1997-11-04 US disclosed
US-5665756-A Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders HOECHST MARION ROUSSEL, INC. (US) 1997-09-09 US disclosed
US-5648367-A ANTIDEPRESANTS, OBSESSIVE-COMPULSIVE DISORDER HOECHST MARION ROUSSEL, INC. (US) 1997-07-15 US disclosed
EP-0709378-A2 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1996-05-01 EP disclosed